Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07696546 · ClinicalTrials.gov registry record · NA
Randomized Trial of Percutaneous vs. Endoscopic Gallbladder Drainage
A NA study, sponsored by Orlando Health.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT07696546: Recruiting NA study, sponsored by Orlando Health.
NCT07696546 is a NA study that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07696546, a NA study, is actively recruiting participants, sponsored by Orlando Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This is a randomized trial of patients with acute calculous cholecystitis who are never-surgery candidates. Patients will be randomized to one of two treatment groups, percutaneous cholecystostomy or endoscopic ultrasound-guided drainage. The aim of the study is to compare between these two treatment methods, the treatment outcomes and quality of life over a follow-up duration of 36 months.
Primary Outcome
A composite endpoint of 1) procedure-related adverse events, 2) reintervention for disease recurrence or procedure-related adverse events, and/or 3) readmission due to underlying disease or procedure-related adverse events, from index procedure to 36 months post-index intervention.
Interventions
- PROCEDURE Percutaneous cholecystostomy
- PROCEDURE EUS-guided gallbladder drainage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2026-07 |
| Est. Completion | 2032-12 |
| Phase | NA |
What NCT07696546 shows while recruiting
NCT07696546 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Percutaneous cholecystostomy is the first listed.
NCT07696546 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07696546 about?
NCT07696546 is a clinical study titled "Randomized Trial of Percutaneous vs. Endoscopic Gallbladder Drainage". This is a randomized trial of patients with acute calculous cholecystitis who are never-surgery candidates. Patients will be randomized to one of two treatment groups, percutaneous cholecystostomy or endoscopic ultrasound-guided drainage. The aim of the study is to compare between these two treatmen...
What is the current status of trial NCT07696546?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2026-07. Estimated completion is 2032-12.
What interventions are being tested in trial NCT07696546?
The interventions under investigation include: Percutaneous cholecystostomy (PROCEDURE), EUS-guided gallbladder drainage (PROCEDURE).
Who is sponsoring clinical trial NCT07696546?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07696546's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia